RK
Ravi Kant Singh
About Ravi Kant Singh
Data last updated:
Ravi Kant Singh is a Director at Averco Global Private Limited (since 2024), Director at Sripharma Lifesciences Private Limited (since 2023) and Director at Amexa Tech Services Private Limited (since 2023), and holds 2 more current directorships. The companies operate in Healthcare, Pharma and Water Treatment. The 5 current companies with reported revenue have a combined latest revenue of ₹1.84 Cr; the largest is Averco Global Private Limited at ₹1.12 Cr (FY 2025). Earlier, Ravi Kant Singh was a Director at Bilib Private Limited (from 2021).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Averco Global Private Limited U33119UP2022PTC167319 | Director | 10 Jun 2024 | 2022 | ₹1.12 Cr (FY 2025) | Active |
 Sripharma Lifesciences Private Limited U46497UP2023PTC195013 | Director | 30 Dec 2023 | 2023 | ₹50.9 Lakh (FY 2025) | Active |
| Amexa Tech Services Private Limited U41002UP2023PTC194702 | Director | 27 Dec 2023 | 2023 | ₹14.1 Lakh (FY 2025) | Active |
| Singh Modular Hospital Infra Private Limited U46596UP2024PTC206312 | Director | 15 Jul 2024 | 2024 | ₹6.4 Lakh (FY 2025) | Active |
| Ryansh Food And Beverages Private Limited U51909UP2022PTC167858 | Whole-Time Director | 19 Jul 2022 | 2022 | ₹1.1 Lakh (FY 2024) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Bilib Private Limited U80900UP2021PTC146173 | Director | 14 May 2021 | 2021 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Ravi Kant Singh
| Name | DIN | Company | Designation |
|---|---|---|---|
| Neeraj Gupta | 08229442 | Averco Global Private Limited | Director |
| Raman Deep Kaur | 07676458 | Averco Global Private Limited , Sripharma Lifesciences Private Limited and 2 more | Director |
| Sri Kant Singh | 07088239 | Averco Global Private Limited , Sripharma Lifesciences Private Limited and 1 more | Ceo |
| Aditya Singh | 07848902 | Singh Modular Hospital Infra Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ravi Kant Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ravi Kant Singh
Ravi Kant Singh currently holds 5 directorships: Averco Global Private Limited (Director, since 10 Jun 2024, revenue ₹1.12 Cr (FY 2025)); Sripharma Lifesciences Private Limited (Director, since 30 Dec 2023, revenue ₹50.9 Lakh (FY 2025)); Amexa Tech Services Private Limited (Director, since 27 Dec 2023, revenue ₹14.1 Lakh (FY 2025)); Singh Modular Hospital Infra Private Limited (Director, since 15 Jul 2024, revenue ₹6.4 Lakh (FY 2025)); Ryansh Food And Beverages Private Limited (Whole-Time Director, since 19 Jul 2022, revenue ₹1.1 Lakh (FY 2024)).
Ravi Kant Singh was first appointed on 14 May 2021 as Director at Bilib Private Limited. The most recent appointment on record is 15 Jul 2024 at Singh Modular Hospital Infra Private Limited.
The 5 current companies of Ravi Kant Singh that report revenue have a combined latest revenue of ₹1.84 Cr: Averco Global Private Limited ₹1.12 Cr (FY 2025); Sripharma Lifesciences Private Limited ₹50.9 Lakh (FY 2025); Amexa Tech Services Private Limited ₹14.1 Lakh (FY 2025); Singh Modular Hospital Infra Private Limited ₹6.4 Lakh (FY 2025); Ryansh Food And Beverages Private Limited ₹1.1 Lakh (FY 2024).
Ravi Kant Singh held 1 earlier board appointment: Bilib Private Limited (Director, from 14 May 2021).
The current boards of Ravi Kant Singh's companies include Neeraj Gupta (Averco Global Private Limited), Raman Deep Kaur (Averco Global Private Limited), Sri Kant Singh (Averco Global Private Limited), Aditya Singh (Singh Modular Hospital Infra Private Limited).